BioSpace News Archive

Policy

Seattle Genetics Submits Supplemental Biologics License Application to FDA for ADCETRIS (Brentuximab Vedotin) in Frontline Advanced Hodgkin Lymphoma

ADCETRIS is being evaluated globally as the foundation of care for CD30-expressing lymphomas in more than 70 corporate- and investigator-sponsored clinical trials.

November 2, 2017

·

15 min read

Drug Development

Mitralign Release: SCOUT I Study Using Trialign System for Transcatheter Tricuspid Repair Continues to Show Positive Outcomes at 1 Year

The data presented by Rebecca Hahn, M.D., New York-Presbyterian/Columbia University Medical Center, continue to demonstrate clinically meaningful results from the study’s first cohort.

November 2, 2017

·

4 min read

Genetown

Alzheon ALZ-801 Data Presented in Oral Session at CTAD on Role of Amyloid Oligomers in Alzheimer’s Disease

The oral presentation reviews the central role of toxic beta amyloid (Aβ) oligomers in the development and progression of AD.

November 2, 2017

·

9 min read

Business

Imricor and MiRTLE Medical Announce Joint Development Agreement to Deliver 12-Lead ECG for Real-Time MRI-Guided Cardiac Ablations

Imricor and MiRTLE Medical announce a joint development agreement to fully integrate MiRTLE’s MR compatible 12-lead ECG system with Imricor’s Advantage-MR™ EP Recorder/Stimulator System.

November 2, 2017

·

2 min read

Business

Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update

Total revenues were $86.8 million in the third quarter of 2017 compared to $66.1 million in the third quarter of 2016.

November 2, 2017

·

36 min read

Biotech Beach

Second Sight Announces Final Medicare Hospital Outpatient Payment Rate for 2018 for the Argus II Retinal Prosthesis System

The payment for the surgical procedure includes the cost of the Argus II.

November 2, 2017

·

4 min read

Drug Development

Second Sight Receives Full FDA Approval to Begin First Orion Human Clinical Study

The approval allows two U.S. sites, the University of California at Los Angeles (UCLA) and Baylor College of Medicine (Baylor) in Houston, to enroll up to five total patients.

November 2, 2017

·

6 min read

Business

Axial Biotherapeutics Strengthens Regulatory Team with Appointment of Dr. Gregory Bates as Senior Vice President of Regulatory Affairs

Dr. Bates will serve on the Axial senior management team and will be responsible for all aspects of regulatory support and operations.

November 2, 2017

·

2 min read

Biotech Bay

BioCardia Announces Reverse Stock Split and Release of Indemnity Holdback Shares

The company’s common stock will begin trading on a split-adjusted basis when the markets open today under the existing trading symbol “BCDA”.

November 2, 2017

·

6 min read

Notice of Knight Therapeutics’ Third Quarter 2017 Results Conference Call

Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.

November 2, 2017

·

2 min read